Post-Operative Nausea & Vomiting Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Post-Operative Nausea & Vomiting Epidemiology Forecast Report Coverage

Expert Market Research's “Post-Operative Nausea & Vomiting Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of post-operative nausea & vomiting. It projects the future incidence and prevalence rates of post-operative nausea & vomiting cases across various populations. The study covers age and type as major determinants of the post-operative nausea & vomiting population. The report highlights patterns in the prevalence of post-operative nausea & vomiting over time and projects future trends based on multiple variables.

Post-Operative Nausea & Vomiting Understanding: Disease Overview

Post-operative nausea & vomiting (PONV) refers to the nausea and vomiting that occur after surgical procedures. It is a common complication, typically within the first 24 hours following surgery. The severity of post-operative nausea & vomiting can range from mild discomfort to severe symptoms that can impact a patient's recovery.

Several factors contribute to the risk of post-operative nausea & vomiting, including gender (with females reported to be more susceptible), age (young children and older adults seem to have a lower risk), the type of surgery performed, and the use of certain anesthetics. Other risk factors include the use of volatile anesthetic agents, opioid analgesics, and a history of motion sickness or previous episodes of post-operative nausea & vomiting.

Post-Operative Nausea & Vomiting Epidemiology Perspective

The post-operative nausea & vomiting epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for post-operative nausea & vomiting epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for the disease and their trends. The post-operative nausea & vomiting detailed epidemiology segmentation is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• A 2024 prospective observational study with 724 patients found that 14.92% experienced post-operative nausea & vomiting (PONV) in the first 6 hours, with 8.29% receiving antiemetics. The incidence of post-operative nausea & vomiting was lowest during the pre-dawn hours (5.66%) and varied by surgery type, with orthopedic surgeries having the highest rate.
• The prevalence rates were 27.7% for post-operative nausea & vomiting, 31.4% for nausea, and 16.8% for vomiting, as per a 2020 systematic review and meta-analysis. Moreover, the prevalence of post-operative nausea & vomiting was found to be higher within the first 24 hours in European countries.
• Global data on post-operative nausea & vomiting is limited, but studies suggest that 20% to 30% of the general population experiences it. Further, 70% to 80% of high-risk patients, such as those undergoing tonsillectomy, strabismus surgery, or laparoscopy, are more likely to be affected by this complication.
• The overall incidence of post-operative nausea & vomiting is estimated to range from 28% to 80%, with severe and persistent cases occurring in about 18% of all patients undergoing surgery.

Read more about this report - Request a Free Sample

Country-wise Post-Operative Nausea & Vomiting Epidemiology Segment

The post-operative nausea & vomiting epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of post-operative nausea & vomiting varies significantly between countries due to differences in factors such as surgical techniques, anesthesia protocols, healthcare infrastructure, the use of antiemetic medications, type of surgeries performed, and patient lifestyle factors (smoking, alcohol consumption, and obesity). In Germany, approximately 2.4 million patients experience post-operative nausea & vomiting each year.

Post-Operative Nausea & Vomiting: Treatment Overview

The first line of post-operative nausea & vomiting treatment usually involves the administration of antiemetic medications. Post-operative nausea & vomiting therapeutics, such as 5-HT3 antagonists (ondansetron), which work by blocking serotonin receptors involved in nausea and vomiting, are commonly used.

Dexamethasone, a corticosteroid, is also recommended for post-operative nausea & vomiting cases, especially in combination with other medications. Dopamine antagonists like metoclopramide and droperidol are an alternative treatment option that can be used to reduce nausea. However, they can cause side effects such as sedation or extrapyramidal symptoms.

Key Questions Answered

• What are the key findings of post-operative nausea & vomiting epidemiology in the 8 major markets?
• What will be the total number of patients with post-operative nausea & vomiting across the 8 major markets during the forecast period?
• What was the country-wise post-operative nausea & vomiting epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of post-operative nausea & vomiting patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of post-operative nausea & vomiting during the forecast period of 2026-2035?
• What are the currently available treatments in the post-operative nausea & vomiting market?
• What are the disease risks, signs, symptoms, and unmet needs of post-operative nausea & vomiting?

Scope of the Post-Operative Nausea & Vomiting Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of post-operative nausea & vomiting based on several factors.
• The Post-Operative Nausea & Vomiting Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The post-operative nausea & vomiting report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Postoperative Pain Epidemiology Forecast

Postoperative Pain Therapeutics Market Size